Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cumberland Pharmaceu (CPIX)

Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,717
  • Shares Outstanding, K 14,957
  • Annual Sales, $ 37,870 K
  • Annual Income, $ -6,480 K
  • EBIT $ 1 M
  • EBITDA $ 6 M
  • 60-Month Beta -0.45
  • Price/Sales 1.72
  • Price/Cash Flow 16.91
  • Price/Book 2.52

Options Overview Details

View History
  • Implied Volatility 286.21% (+24.42%)
  • Historical Volatility 97.83%
  • IV Percentile 69%
  • IV Rank 23.99%
  • IV High 1,000.24% on 08/12/25
  • IV Low 60.88% on 11/20/25
  • Expected Move (DTE 22) 1.87 (44.52%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 17
  • Volume Avg (30-Day) 425
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 7,119
  • Open Int (30-Day) 4,640
  • Expected Range 2.33 to 6.07

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.06 +103.88%
on 11/25/25
4.59 -8.55%
on 12/22/25
+2.13 (+102.90%)
since 11/24/25
3-Month
1.85 +127.03%
on 11/18/25
4.59 -8.55%
on 12/22/25
+1.14 (+37.25%)
since 09/24/25
52-Week
1.85 +127.03%
on 11/18/25
7.25 -42.07%
on 03/05/25
+1.69 (+67.33%)
since 12/24/24

Most Recent Stories

More News
CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT

NASHVILLE, Tenn. , Dec. 8, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), today announced an important update regarding its Caldolor ® (ibuprofen) Injection. The product's...

CPIX : 4.20 (-1.41%)
Cumberland: Q3 Earnings Snapshot

Cumberland: Q3 Earnings Snapshot

CPIX : 4.20 (-1.41%)
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH

NASHVILLE, Tenn. , Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved...

CPIX : 4.20 (-1.41%)
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE

NASHVILLE, Tenn. , Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that it will release its third quarter 2025...

CPIX : 4.20 (-1.41%)
CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO

 Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy

RDHL : 1.1500 (-2.95%)
CPIX : 4.20 (-1.41%)
CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.

Premier Membership includes 4,350 U.S. Hospitals

CPIX : 4.20 (-1.41%)
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO

Injectable Ibuprofen Approved for Treating Pain & Fever

CPIX : 4.20 (-1.41%)
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA

Vibativ ®  treats patients with pneumonia and serious skin infections

CPIX : 4.20 (-1.41%)
Cumberland: Q2 Earnings Snapshot

Cumberland: Q2 Earnings Snapshot

CPIX : 4.20 (-1.41%)
Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date

NASHVILLE, Tenn. , Aug. 5, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved...

CPIX : 4.20 (-1.41%)

Business Summary

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in...

See More

Key Turning Points

3rd Resistance Point 4.44
2nd Resistance Point 4.37
1st Resistance Point 4.28
Last Price 4.20
1st Support Level 4.12
2nd Support Level 4.05
3rd Support Level 3.96

See More

52-Week High 7.25
Fibonacci 61.8% 5.19
Fibonacci 50% 4.55
Last Price 4.20
Fibonacci 38.2% 3.91
52-Week Low 1.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar